UK markets closed

CytoMed Therapeutics Limited (GDTC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.9000-0.1500 (-7.32%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in SGD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-4,133
-4,133
-3,131
-2,052
-1,935
Depreciation & amortisation
381.148
381.148
392.867
329.878
292.533
Change in working capital
104.918
104.918
109.902
-369.248
115.591
Other working capital
-3,491
-3,491
-1,872
-2,295
-1,115
Other non-cash items
-234.437
-234.437
123.078
114.327
105.519
Net cash provided by operating activities
-3,433
-3,433
-1,398
-1,713
-849.443
Cash flows from investing activities
Investments in property, plant and equipment
-58.295
-58.295
-473.795
-582.354
-265.155
Acquisitions, net
0
0
0
-241.312
0
Purchases of investments
-2,771
-2,771
0
0
-247.899
Net cash used for investing activities
-2,829
-2,829
-473.305
-823.666
-513.054
Cash flows from financing activities
Debt repayment
-340.426
-340.426
-428.759
-58.908
-10.959
Common stock issued
11,307
11,307
1,223
2,000
500
Dividends paid
0
0
0
0
0
Other financing activities
-
-
-
2,000
-
Net cash used provided by (used for) financing activities
10,920
10,920
968.716
4,173
1,884
Net change in cash
4,658
4,658
-902.998
1,637
521.025
Cash at beginning of period
1,580
1,580
2,513
885.272
370.942
Cash at end of period
6,224
6,224
1,580
2,513
885.272
Free cash flow
Operating cash flow
-3,433
-3,433
-1,398
-1,713
-849.443
Capital expenditure
-58.295
-58.295
-473.795
-582.354
-265.155
Free cash flow
-3,491
-3,491
-1,872
-2,295
-1,115